USP Txa Medication API CAS NO 1197-18-8 Antifibrinolytic Drugs Powder

Product Description

Tranexamic Acid USP EP JP CP CAS No.1197-18-8  

Tranexamic Acid is a an antifibrinolytic for blocking lysine-binding sites of plasmin and Tranexamic Aicd is also known as an unique whitening skincare ingredient.

Xi'an Libang Pharmaceutical Co..Ltd developed Tranexamic Acid in 2018 as the third-biggest GMP manufacturer in China. 

Tranexamic Aicd produced by Libang is in compliance with USP, EP, JP and CP, can be used for oral grade and injectable grade. 

Who we are:

XI’AN LIBANG PHARMACEUTICAL CO.,LTD. founded in 1996 with a location in Xi’an City of China, the center of the northwest pharmaceutical industry, is specialized in research, development, production and distribution of specialty pharmaceutical products. As the first and also largest supplier of generic Propofol in China, LIBANG started its business and subsequently launched a broad portfolio finished dosage forms covering anesthetics, cardiovascular, antineoplastic, clinical nutrition etc.

With more than 20 years growth, LIBANG has transformed into an integrated health care solution provider, LIBANG HEALTHCARE GROUP, with diversified fields covering high value-added APIs, pharmaceutical excipients, prescription drugs, OTC products, biomedicine, medical devices.

LIBANG is a technology-driven firm, with more than 8% of the annual sales revenues devoted to research and innovation, establishing a unique R&D platform to proactively follow the latest pharmaceutical technology frontier.

LIBANG now is one of Top 100 China’s Pharmaceutical Industries and also listed in the Top 20 The Most Potential Chinese Pharmaceuticals that was rated by the IMS Health.